Eye toxicity from cancer chemotherapy is uncommon, but important because of the debility caused by loss of vision. The literature describing eye toxicity is reviewed for commonly used antineoplastic agents.
No takes yet. Share an insight, caveat, or question.
Griffin et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: